Literature DB >> 35809092

Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVD-19 patients.

Ahmed H Abdelazim1.   

Abstract

Entities:  

Keywords:  COVID-19; Olfactory dysfunction

Mesh:

Substances:

Year:  2022        PMID: 35809092      PMCID: PMC9282138          DOI: 10.1007/s00405-022-07540-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


× No keyword cloud information.
Dear Editor: I would like to thank Yuce İslamoglu for the pertinent reference to the COVID-19 variant in our recent study testing the use of intra-nasal nitrilotriacetic acid trisodium salt to improve olfactory dysfunction in COVD-19 patients [1]. I carefully read the article by Yuce İslamoglu et al. which investigated the difference in nasal mucosal secretion between anosmic COVID-19 patients, dominant Wuhan COVID-19 variant and healthy subjects. The results showed that there was no difference between the groups [2]. As shown by different studies, different variants have different effects on nasal mucosa [3-5]. In our study, the Wuhan variant was the dominant COVID-19 variant.
  1 in total

1.  Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVD-19 patients.

Authors:  Ahmed H Abdelazim
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-09       Impact factor: 3.236

  1 in total
  2 in total

1.  Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVD-19 patients.

Authors:  Ahmed H Abdelazim
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-09       Impact factor: 3.236

2.  Effect of intranasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients.

Authors:  Yuce İslamoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-13       Impact factor: 3.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.